Bibliografía del artículo
1. De Marco T, McGlothin D. Managing right ventricular failure in pulmonary artery hypertension: an algorithmic approach. Advances in Pulmonary Hypertension 4:16-26, 2005.
2. Oudiz RJ. The role of exercise testing in the management of pulmonary arterial hypertension. Sem Resp Crit Car Med 26(4):379-84, 2005.
3. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104:429-35, 2001.
4. McLaughlin V, Presberg KW, Doyle RL, Abman SH, McCrory D, Fortin T, et al. Prognosis of pulmonary arterial hypertension. Chest 126:78S-92S, 2004.
5. Raphael C, Briscoe C, Davies J, Ian Whinnett J, Manistry C, Sutton R, et al. Limitations of New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93(4):476-82, 2007.
6. Enright Pl, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 158:1384-87, 1998.
7. Guazzi M, Opasich C. Functional evaluation of patients with chronic pulmonary hypertension. Ital Heart J 6(10):789-94, 2005.
8. Torbicki A, Kurzyna M. Pulmonary arterial hypertension: evaluation of the newly diagnosed patient. Sem Resp Crit Care Med 26(4):372-8, 2005.
9. Frost AE, Langleben D, Oudiz R, Hill N, Horn E, McLaughlin V, et al. The 6-minute walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascular Pharmacology 43:35-39, 2005.
10. Hoeper MM, Oudiz RJ, Peacock A, Tapson VF, Haworth SG, Frost AE, et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 43(12 Suppl S):48 S-55S, 2004.
11. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamai F, Fujita M, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Am J Respir Crit Care Med 161:487-92, 2000.
12. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Principles of exercise testing and interpretation. 4th ed. Baltimore, Md: Lippincott Williams & Wilkins; 2004.
13. Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169:441-7, 2004.
14. Oudiz RJ, Barst RJ, Hansen JE, Sun XG, Garofano R, Xu X, et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 997:123-6, 2006.
15. López Chicharro J, Fernández Vaquero A. Fisiología del ejercicio. 3ª Edición. En: Editorial Médica Panamericana SA (ed) Madrid: 2006.
16. Task Force of the Italian Working Group on Cardiac Rehabilitation Prevention endorsed by the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I: definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil 13:150-64, 2006.
17. Sun XG, Hanse E, Garatachea N, et al. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med 166:1443-8, 2002.
18. Corrà U, Mezzani A, Bosimini E, Gianuzzi P. Cardiopulmonary exercise testing and prognosis in chronic heart failure. Chest 126:942-50, 2004.
19. Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P, Guazzi M. Development of a ventilatory classification system in patients with heart failure. Circulation 115:2410-17, 2007.
20. Task Force of the Italian Working Group on Cardiac Rehabilitation Prevention endorsed by the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part II: How to perform cardiopulmonary exercise testing in chronic heart failure. Eur J Cardiovasc Prev Rehabil 13:300-11, 2006.
21. Riley MS, Pórszász J, Marïelle P, et al. Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans. Eur J Appl Physiol 83:63-70, 2000.
22. Yasunobu Y, Oudiz RJ, Sun XG, et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 127:1637-46, 2005.
23. Deboeck G, Niset G, Lamotte M, et al. Exercise testing in pulmonary arterial hypertension and in chronic heart failure. Eur Respir J 23:747-51, 2004.
24. Sun XG, Hansen JE, Oudiz RJ, et al. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation 105:54-60, 2002.
25. Yetman AT, Taylon AL, Doran A, et al. Utility of cardiopulmonary stress testing in assessing disease severity in children with pulmonary arterial hypertension. Am J Cardiol 95:697-699, 2005.
26. Hansen JE, Sun XG, Yasunobu Y, et al. Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension. Chest 126:816-24, 2004.
27. Wensel R, Opitz CF, Anker SD, Winkler J, Höffken G, Kleber FX, et al. Assessment of survival in patients with primary pulmonary hypertension. Importance of cardiopulmonary exercise testing. Circulation 106:319-24, 2002.